First line chemotherapy with planned sequential administration of gemcitabine followed by docetaxel in elderly advanced non-small-cell lung cancer patients: a multicenter phase II study

This multicenter phase II study evaluated, in chemonaive patients with stage IIIB–IV NSCLC, age ⩾70 and with a performance status 0–2, the activity, efficacy and tolerability of planned sequential administration of gemcitabine 1200 mg m(−2) on days 1 and 8 every 3 weeks for three courses followed by...

Descripción completa

Detalles Bibliográficos
Autores principales: Tibaldi, C, Vasile, E, Antonuzzo, A, Di Marsico, R, Fabbri, A, Innocenti, F, Tartarelli, G, Amoroso, D, Andreuccetti, M, Dico, M Lo, Falcone, A
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2008
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2243160/
https://www.ncbi.nlm.nih.gov/pubmed/18212755
http://dx.doi.org/10.1038/sj.bjc.6604187

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2243160/
https://www.ncbi.nlm.nih.gov/pubmed/18212755
http://dx.doi.org/10.1038/sj.bjc.6604187

Ejemplares similares